Parsippany, New Jersey. Edenbridge Pharmaceuticals, LLC announces that it has received final approval from the U.S. Food and Drug Administration on its Abbreviated New Drug Application for Prednisolone Sodium Phosphate Oral Solution to include the 15 mg Prednisolone per 5 mL and 25mg Prednisolone per 5 mL strengths. With this approval Edenbridge can now offer four strengths of Prednisolone Sodium Phosphate Oral Solution: 10 mg Prednisolone per 5 mL, 15mg Prednisolone per 5 mL, 20 mg Prednisolone per 5 mL, and 25mg Prednisolone per 5 mL. For more information please contact the Company directly at info@dexcelpharmausa.com.
Prednisolone Sodium Phosphate Oral Solution (15mg per 5mL & 25mg per 5mL) Approval
Specialty Products
To learn more about our specialty products, vigabatrin and Yargesa®, and how you may be able to save, please visit the Products page or navigate to a product-specific page.
Specialty Products
To learn more about our specialty products, vigabatrin and Yargesa®, and how you may be able to save, please visit the Products page or navigate to a product-specific page.